Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · IEX Real-Time Price · USD
-0.010 (-1.02%)
At close: Mar 27, 2023, 3:53 PM
-0.015 (-1.48%)
After-hours: Mar 27, 2023, 4:00 PM EDT

Company Description

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally.

The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis.

It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds.

In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation.

The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016.

Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.

Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals logo
Country United States
IPO Date Jan 25, 2007
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 12
CEO Ms. Amy M. Trombly

Contact Details

5445 Conestoga Court, Suite 150
Boulder, Colorado 80301
United States
Phone 800-759-9305

Stock Details

Ticker Symbol SNOA
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001367083
CUSIP Number 83558L204
ISIN Number US83558L2043
Employer ID 68-0423298
SIC Code 2834

Key Executives

Name Position
Amy M. Trombly Chief Executive Officer, President and Director
Bruce Thornton Chief Operating Officer and Corporate Secretary
Jerome Dvonch Executive Officer
Chad White Interim Chief Financial Officer
Dr. Robert Northey Executive Vice President of Research & Development
Victoria Covel Assistant Controller

Latest SEC Filings

Date Type Title
Feb 24, 2023 424B5 Filing
Feb 24, 2023 8-K Current Report
Feb 14, 2023 10-Q Quarterly Report
Jan 31, 2023 8-K Current Report
Jan 6, 2023 8-K Current Report
Dec 30, 2022 8-K Current Report
Dec 23, 2022 8-K Current Report
Dec 23, 2022 424B3 Prospectus
Nov 14, 2022 10-Q Quarterly Report
Oct 7, 2022 8-K Current Report